ArticleFrontiers in surgery2026
Microchannel-assisted precision surgical treatment for thoracic ossification of the ligamentum flavum: a comparative retrospective study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate the clinical efficacy of the microchannel-assisted technique for precise treatment in patients with focal thoracic ossification of the ligamentum flavum. Methods: We retrospectively reviewed the clinical data of 38 patients diagnosed with focal thoracic ossification of the ligamentum flavum (TOLF) who underwent surgical treatment in the Department of Spine Surgery, The Cangzhou Hospital of Integrated TCM-WM Hebei, between January 2018 and December 2022. The patients were divided into two groups according to whether the microchannel-assisted technique was used during surgery: group A (microchannel-assisted group, Results: None of the patients in either group experienced postoperative neurological deterioration. No statistically significant difference was observed in the JOA score improvement rate at the 2-year follow-up between the two groups (group A: 63.74 ± 18.55, group B: 61.56 ± 17.94, Conclusions: This study confirms that the microchannel-assisted technique is a safe and effective minimally invasive treatment for focal thoracic ossification of the ligamentum flavum. This technique significantly reduces operative time, decreases intraoperative blood loss, promotes postoperative recovery, and lowers complication rates while ensuring comparable long-term neurological outcomes. These advantages are attributed to the concept of "precise decompression" and the preservation of paraspinal muscleoskeletal structures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.